Health and Human Services News and Research

RSS

Study reveals higher prevalence of epilepsy among sexual and gender minorities

Sexual and gender minorities (SGM) - individuals who identify as gay, lesbian, bisexual, queer, transgender, non-binary, or gender-diverse - are twice as likely to report active epilepsy compared to non-SGM individuals, based on a National Institutes of Health (NIH) analysis of data from the population-based National Health Information Survey.

22 Jul 2024

New national guidelines for anal cancer prevention in HIV patients based on UCSF research

New recommendations for screening and treatment are based on the results of a major national study led at UCSF.

19 Jul 2024

Misleading ads play key role in schemes to gin up unauthorized ACA sign-ups, lawsuit alleges

The government is giving away money! So say ads on a variety of social media platforms. Consumers, the ads claim, can qualify for $1,400 or even $6,400 a month to use on groceries, rent, medical expenses, and other bills.

19 Jul 2024

Trump is wrong in claiming full credit for lowering insulin prices

"Low INSULIN PRICING was gotten for millions of Americans by me, and the Trump Administration, not by Crooked Joe Biden. He had NOTHING to do with it."

18 Jul 2024

Daily supplement may help preserve vision in people with late-stage dry AMD

In a new analysis of data, researchers at the National Institutes of Health (NIH) have found that taking a daily supplement containing antioxidant vitamins and minerals slows progression of late-stage dry age-related macular degeneration (AMD), potentially helping people with late-stage disease preserve their central vision.

16 Jul 2024

ECHO study sheds light on how neighborhood environment influenced child's well-being amid pandemic

The COVID-19 pandemic significantly disrupted daily life and has raised concerns about its impact on children's well-being.

12 Jul 2024

Cellular immunotherapy offers hope for solid tumors

Early findings from a small clinical trial provide evidence that a new cellular immunotherapy approach may be effective in treating metastatic solid tumors. In the trial, researchers from the National Institutes of Health (NIH) genetically engineered normal white blood cells, known as lymphocytes, from each patient to produce receptors that recognize and attack their specific cancer cells.

12 Jul 2024

Study finds disparities in heart bypass surgery for women

Women over the age of 65 who require complex heart surgery are more likely than men to receive care at low quality hospitals - where they also die in greater numbers following the procedure, a Michigan Medicine study finds.

11 Jul 2024

Repurposing cancer drug to prevent organ damage in infectious diseases

Twelve years ago, cancer researchers at University of California San Diego identified a molecule that helps cancer cells survive by shuttling damaging inflammatory cells into tumor tissue.

3 Jul 2024

NIH scientists uncover brain circuitry behind face detection in primates

Scientists at the National Institutes of Health (NIH) have uncovered a brain circuit in primates that rapidly detects faces.

2 Jul 2024

Mississippi lacks Black doctors, even as lawmakers increasingly target diversity programs

Jerrian Reedy was 9 when his father was admitted to the hospital in Hattiesburg, about two hours northeast of New Orleans, after sustaining three gunshot wounds.

2 Jul 2024

NIH launches Phase 1 trial for innovative nasal COVID-19 vaccine

A Phase 1 trial testing the safety of an experimental nasal vaccine that may provide enhanced breadth of protection against emerging variants of SARS-CoV-2, the virus that causes COVID-19, is now enrolling healthy adults at three sites in the United States.

1 Jul 2024

Survey reveals public awareness gaps in opioid use disorder treatment by primary care physicians

Results from a national survey indicate that many Americans, 61%, are unaware that primary care physicians can prescribe medications for opioid use disorder, and 13% incorrectly believed that they could not.

28 Jun 2024

Clinical trial seeks to evaluate safety of new EV-D68 treatment

The National Institutes of Health (NIH) is sponsoring a clinical trial to evaluate the safety of an investigational monoclonal antibody to treat enterovirus D68 (EV-D68), which can cause severe respiratory and neurological diseases such as acute flaccid myelitis (AFM) – similar to polio. Scientists are striving to better understand AFM, which has emerged in the United States with spikes in cases every other year, primarily in the late-summer months over the last decade.

28 Jun 2024

Study shows how milking equipment spreads bird flu risk

Bird flu, or H5N1 virus, in unpasteurized milk is stable on metal and rubber components of commercial milking equipment for at least one hour, increasing its potential to infect people and other animals, report researchers from the University of Pittsburgh School of Medicine and Emory University in Emerging Infectious Diseases.

28 Jun 2024

Battleground Wisconsin: Voters feel nickel-and-dimed by health care costs

The land of fried cheese curds and the Green Bay Packers is among a half-dozen battleground states that could determine the outcome of the expected November rematch between President Joe Biden and former President Donald Trump — a contest in which the cost and availability of health care are emerging as defining issues.

27 Jun 2024

NIAID scientists discover probiotic treatment for eczema

NIAID research has led to the availability of a new over-the-counter topical eczema probiotic.

26 Jun 2024

Analysis reveals no link between multivitamin use and reduced mortality

A large analysis of data from nearly 400,000 healthy U.S. adults followed for more than 20 years has found no association between regular multivitamin use and lower risk of death.

26 Jun 2024

Lenacapavir: A breakthrough in long-acting HIV prevention for cisgender women

The injectable antiretroviral drug lenacapavir was safe and 100% effective as long-acting HIV pre-exposure prophylaxis (PrEP) among cisgender women in a Phase 3 clinical trial, according to top-line findings released by Gilead Sciences, Inc., the study sponsor.

26 Jun 2024